IN BRIEF: International Biotechnology Trust NAV rises over interim

International Biotechnology Trust PLC - investment trust run by SV Health Managers LLP - reports ...

Alliance News 26 April, 2021 | 1:35PM
Email Form Facebook Twitter LinkedIn RSS

International Biotechnology Trust PLC - investment trust run by SV Health Managers LLP - reports net asset value as of February 28 increased to 776 pence per share from 739p per share as at August 31. Net asset value on total return was 6.9% in period, underperforming benchmark Nasdaq Biotechnology Index return of 12%. Pretax profit more than doubled year-on-year to GBP19.1 million from GBP9.3 million.

Underperformance versus benchmark attributed to unsustainably high valuations of early-stage companies with no clinical data, which International Biotechnology Trust did not invest in. Investment strategy and dividend policy remain unchanged. Company will continue to issue shares at premium to net asset value to satisfy market demand.

Current stock price: 748.00 pence

Year-to-date change: down 8.5%

By Ivan Edwards; ivanedwards@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
International Biotechnology Ord 708.00 GBX 2.02

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures